Cargando…

Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice

Oxidative stress is an essential factor in the development and progression of Alzheimer’s disease (AD). An excessive amount of reactive oxygen species (ROS) induces the peroxidation of lipid membranes, reduces the activity of antioxidant enzymes and causes neurotoxicity. In this study, we investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeonova, Rumyana, Atanasova, Mariyana, Stavrakov, Georgi, Philipova, Irena, Doytchinova, Irini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737725/
https://www.ncbi.nlm.nih.gov/pubmed/36499171
http://dx.doi.org/10.3390/ijms232314843
_version_ 1784847360629669888
author Simeonova, Rumyana
Atanasova, Mariyana
Stavrakov, Georgi
Philipova, Irena
Doytchinova, Irini
author_facet Simeonova, Rumyana
Atanasova, Mariyana
Stavrakov, Georgi
Philipova, Irena
Doytchinova, Irini
author_sort Simeonova, Rumyana
collection PubMed
description Oxidative stress is an essential factor in the development and progression of Alzheimer’s disease (AD). An excessive amount of reactive oxygen species (ROS) induces the peroxidation of lipid membranes, reduces the activity of antioxidant enzymes and causes neurotoxicity. In this study, we investigated the antioxidant and cholinesterase inhibitory potential of a novel galantamine–curcumin hybrid, named 4b, administered orally in two doses (2.5 mg/kg and 5 mg/kg) in scopolamine (SC)-induced neurotoxicity in mice. To evaluate the effects of 4b, we used galantamine (GAL) (3 mg/kg) and curcumin (CCN) (25 mg/kg) as positive controls. Ex vivo experiments on mouse brains showed that the higher dose of 4b (5 mg/kg) increased reduced glutathione (GSH) levels by 46%, catalase (CAT) and superoxide dismutase (SOD) activity by 57%, and glutathione peroxidase (GPx) activity by 108%, compared with the SC-treated group. At the same time, 4b (5 mg/kg) significantly reduced the brain malondialdehyde (MDA) level by 31% and acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activities by 40% and 30%, respectively, relative to the SC-impaired group. The results showed that 4b acted as an antioxidant agent and brain protector, making it promising for further experimental research in the field of neurodegenerative diseases.
format Online
Article
Text
id pubmed-9737725
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97377252022-12-11 Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice Simeonova, Rumyana Atanasova, Mariyana Stavrakov, Georgi Philipova, Irena Doytchinova, Irini Int J Mol Sci Communication Oxidative stress is an essential factor in the development and progression of Alzheimer’s disease (AD). An excessive amount of reactive oxygen species (ROS) induces the peroxidation of lipid membranes, reduces the activity of antioxidant enzymes and causes neurotoxicity. In this study, we investigated the antioxidant and cholinesterase inhibitory potential of a novel galantamine–curcumin hybrid, named 4b, administered orally in two doses (2.5 mg/kg and 5 mg/kg) in scopolamine (SC)-induced neurotoxicity in mice. To evaluate the effects of 4b, we used galantamine (GAL) (3 mg/kg) and curcumin (CCN) (25 mg/kg) as positive controls. Ex vivo experiments on mouse brains showed that the higher dose of 4b (5 mg/kg) increased reduced glutathione (GSH) levels by 46%, catalase (CAT) and superoxide dismutase (SOD) activity by 57%, and glutathione peroxidase (GPx) activity by 108%, compared with the SC-treated group. At the same time, 4b (5 mg/kg) significantly reduced the brain malondialdehyde (MDA) level by 31% and acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activities by 40% and 30%, respectively, relative to the SC-impaired group. The results showed that 4b acted as an antioxidant agent and brain protector, making it promising for further experimental research in the field of neurodegenerative diseases. MDPI 2022-11-27 /pmc/articles/PMC9737725/ /pubmed/36499171 http://dx.doi.org/10.3390/ijms232314843 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Simeonova, Rumyana
Atanasova, Mariyana
Stavrakov, Georgi
Philipova, Irena
Doytchinova, Irini
Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
title Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
title_full Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
title_fullStr Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
title_full_unstemmed Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
title_short Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
title_sort ex vivo antioxidant and cholinesterase inhibiting effects of a novel galantamine–curcumin hybrid on scopolamine-induced neurotoxicity in mice
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737725/
https://www.ncbi.nlm.nih.gov/pubmed/36499171
http://dx.doi.org/10.3390/ijms232314843
work_keys_str_mv AT simeonovarumyana exvivoantioxidantandcholinesteraseinhibitingeffectsofanovelgalantaminecurcuminhybridonscopolamineinducedneurotoxicityinmice
AT atanasovamariyana exvivoantioxidantandcholinesteraseinhibitingeffectsofanovelgalantaminecurcuminhybridonscopolamineinducedneurotoxicityinmice
AT stavrakovgeorgi exvivoantioxidantandcholinesteraseinhibitingeffectsofanovelgalantaminecurcuminhybridonscopolamineinducedneurotoxicityinmice
AT philipovairena exvivoantioxidantandcholinesteraseinhibitingeffectsofanovelgalantaminecurcuminhybridonscopolamineinducedneurotoxicityinmice
AT doytchinovairini exvivoantioxidantandcholinesteraseinhibitingeffectsofanovelgalantaminecurcuminhybridonscopolamineinducedneurotoxicityinmice